EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Developing Vaccines in Pancreatic Adenocarcinoma: Trials and Tribulations

Thuy Phan, Darrell Fan iD, Laleh G Melstrom

Current Oncology · 2024

DOI: 10.3390/curroncol31090361 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Oncology, 2024. Verfasst von Thuy Phan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, City of Hope National Medical Center, Duarte, CA 91010, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Cancer Vaccines, Adenocarcinoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 239 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic adenocarcinoma represents one of the most challenging malignancies to treat, with dismal survival rates despite advances in therapeutic modalities. Immunotherapy, particularly vaccines, has emerged as a promising strategy to harness the body’s immune system in combating this aggressive cancer. This abstract reviews the trials and tribulations encountered in the development of vaccines targeting pancreatic adenocarcinoma. Key challenges include the immunosuppressive tumor microenvironment, the heterogeneity of tumor antigens, and a limited understanding of immune evasion mechanisms employed by pancreatic cancer cells. Various vaccine platforms, including peptide-based, dendritic cell-based, and viral vector-based vaccines, have been explored in preclinical and clinical settings. However, translating promising results from preclinical models to clinical efficacy has proven elusive. In recent years, mRNA vaccines have emerged as a promising immunotherapeutic strategy in the fight against various cancers, including pancreatic adenocarcinoma. We will discuss the potential applications, opportunities, and challenges associated with mRNA vaccines in pancreatic cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCancer VaccinesAdenocarcinomaHumansImmunotherapyClinical Trials as TopicTumor Microenvironment

Stichwörter der Autor:innen

mRNAneoantigenspancreatic cancervaccine

Substanzen

Cancer Vaccines

Autor:innen und Institutionen

  • Department of Surgery, City of Hope National Medical Center, Duarte, CA 91010, USA.
  • Department of Surgical Oncology, City of Hope National Medical Center, Duarte, CA 91010, USA.

ORCID-Profile: Darrell Fan

Zitieren

APA

Phan, T., Fan, D., & Melstrom, L. G. (2024). Developing Vaccines in Pancreatic Adenocarcinoma: Trials and Tribulations. Current Oncology. https://doi.org/10.3390/curroncol31090361

Vancouver

Phan T, Fan D, Melstrom LG. Developing Vaccines in Pancreatic Adenocarcinoma: Trials and Tribulations. Current Oncology. 2024. doi:10.3390/curroncol31090361

BibTeX
@article{Phan2024,
  author = {Phan, Thuy and Fan, Darrell and Melstrom, Laleh G},
  title = {Developing Vaccines in Pancreatic Adenocarcinoma: Trials and Tribulations},
  journal = {Current Oncology},
  year = {2024},
  doi = {10.3390/curroncol31090361}
}
Kostenlos starten →